Litigation Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2015)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2015)
Docket | ⤷ Subscribe | Date Filed | 2015-11-12 |
Court | District Court, D. Delaware | Date Terminated | 2018-01-07 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 8,436,010 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-02-27 | 38 | STIPULATION and Proposed Order Regarding U.S. Patent 8,436,010, by Novartis Pharmaceuticals Corporation. …2015 8 January 2018 1:15-cv-01050 830 Patent None District Court, D. Delaware | External link to document | |
2017-02-28 | 39 | Granting 38 Stipulation and Order Regarding U.S. Patent 8,436,010. Signed by Judge Richard G. Andrews on 3/1…2015 8 January 2018 1:15-cv-01050 830 Patent None District Court, D. Delaware | External link to document | |
2015-11-12 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,436,010. (nmb) (Entered: 11…2015 8 January 2018 1:15-cv-01050 830 Patent None District Court, D. Delaware | External link to document | |
2017-10-09 | 49 | . Burris, III Regarding Validity of U.S. Patent No. 8,436,010 and (2) Responsive Expert Report of Dr. …. Richard S. Finn Regarding Validity of U.S. Patent No. 8,36,010 filed by Novartis Pharmaceuticals Corporation…2015 8 January 2018 1:15-cv-01050 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |